Elanco Animal Health (NASDAQ:ELAN) issued an update on its FY19 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $1.04-1.10 for the period, compared to the Thomson Reuters consensus estimate of $1.09. The company issued revenue guidance of $3.08-3.12 billion, compared to the consensus revenue estimate of $3.11 billion.
ELAN stock opened at $29.85 on Wednesday. Elanco Animal Health has a twelve month low of $28.00 and a twelve month high of $37.61. The business’s fifty day moving average price is $33.09.
Elanco Animal Health (NASDAQ:ELAN) last released its earnings results on Tuesday, August 13th. The company reported $0.28 earnings per share for the quarter, topping analysts’ consensus estimates of $0.26 by $0.02. The firm had revenue of $781.60 million for the quarter, compared to the consensus estimate of $781.49 million. The business’s quarterly revenue was up 1.5% compared to the same quarter last year.
Elanco Animal Health Company Profile
There is no company description available for Elanco Animal Health Inc
Featured Article: How accurate is the Rule of 72?
Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.